Uncertainty-aware ensemble of foundation models differentiates glioblastoma from its mimics

Comprehensive Summary

To improve glioblastoma diagnoses and distinguish it from central nervous system cancers, this study created the Pathology Image Characterization Tool with Uncertainty-aware Rapid Evaluations (PICTURE) system using a large-scale worldwide source of pathology slides. In particular, the PICTURE system uses Bayesian inference, deep ensemble, and normalizing flow to address the uncertainties in diagnoses. The study found that the PICTURE system is very accurate in diagnosing both glioblastoma and primary central nervous system (AUROC = 0.989) while also identifying numerous samples belonging to rare central central system cancers, among which none are gliomas or lymphomas. The rapid, accurate, and generalizable nature of the PICTURE system indicates a novel approach to differentiating glioblastoma from central nervous system cancers in a more effective manner.

Outcomes and Implications

Both primary central nervous system lymphomas and glioblastoma pathologies have overlapping characteristics, making it especially difficult to distinguish diagnoses. In order to properly manage a patient's conditions, an accurate diagnosis is critical. The PICTURE system provides a novel AI method that can accurately and efficiently distinguish between primary central nervous system cancers and glioblastoma. As a result, this system holds potential to decrease misdiagnoses and to improve health outcomes for patients. The PICTURE system may be a useful tool health care providers can employ to ensure accuracy in difficult diagnoses such as primary central nervous system cancers and glioblastomas and, in doing so, may improve treatment outcomes in patients.